Clinical trials
Hyperlipidemias trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
86 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 7 |
| 2012 | 4 |
| 2013 | 13 |
| 2014 | 8 |
| 2015 | 7 |
| 2016 | 8 |
| 2017 | 10 |
| 2018 | 7 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 68 |
| Unknown status | 10 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chong Kun Dang Pharmaceutical | 7 |
| Yuhan Corporation | 7 |
| Addpharma Inc. | 6 |
| Chonbuk National University Hospital | 6 |
| Hanmi Pharmaceutical Company Limited | 6 |
| Boryung Pharmaceutical Co., Ltd | 5 |
| Jeil Pharmaceutical Co., Ltd. | 5 |
| Pfizer | 5 |
| Amgen | 4 |
| HK inno.N Corporation | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 86 |
| Hypertension | 36 |
| Diabetes Mellitus | 6 |
| Hypercholesterolemia | 5 |
| Cardiovascular Diseases | 4 |
| Essential Hypertension | 3 |
| Atherosclerosis | 2 |
| Coronary Artery Disease | 2 |
| Dyslipidemias | 2 |
| Hypertriglyceridemia | 2 |
Trials
Showing 1 to 25 of 86. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.